Advertisement

Topics

Starpharma shares up 9% on vaginal disorder trial results

11:25 EDT 7 Aug 2017 | thePharmaLetter

The share price of Australian biotech Starpharma soared by 9% to A$0.83 on Monday on news of the company’s…

Original Article: Starpharma shares up 9% on vaginal disorder trial results

NEXT ARTICLE

More From BioPortfolio on "Starpharma shares up 9% on vaginal disorder trial results"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Searches Linking to this Story